the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome.
Timeframe: up to 120 minutes after the Arginine infusion.